Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy.
Centre of Advanced Research in Bionanoconjugates and Biopolymers Department, "Petru Poni" Institute of Macromolecular Chemistry, 700487 Iasi, Romania.
Int J Mol Sci. 2020 Mar 7;21(5):1842. doi: 10.3390/ijms21051842.
Schistosomiasis is a debilitating infection provoked by parasitic flatworms called schistosomes. The species is endemic in Africa, where it causes intestinal schistosomiasis. Recently, an α-carbonic anhydrase (CA, EC 4.2.1.1) was cloned and characterized from this organism and designated as SmCA. The protein is expressed in the tegument (skin) of . at the host-parasite interface. Recombinant SmCA possesses high catalytic activity in the CO hydration reaction, similar to that of human CA isoform II with a k of 1.2 × 10 s and a k/K of 1.3 × 10 M·s. It has been found that schistosomes whose SmCA gene is suppressed using RNA interference are unable to establish a robust infection in mice, suggesting that the chemicals that inhibit SmCA function should have the same debilitating effect on the parasites. In this study, a collection of aromatic/heterocyclic sulfonamides were investigated as possible SmCA inhibitors. Several sulfonamides inhibited SmCA with medium to weak potency (K values of 737.2 nM-9.25 μM), whereas some heterocyclic compounds inhibited the enzyme with K values in the range of 124-325 nM. The α-CA from , SmCA, is proposed as a new anti-schistosomiasis drug target.
血吸虫病是一种由寄生扁形动物血吸虫引起的使人虚弱的感染。 该物种在非洲流行,在那里它引起肠道血吸虫病。最近,从这种生物中克隆并表征了一种α-碳酸酐酶(CA,EC 4.2.1.1),并将其命名为 SmCA。该蛋白在宿主-寄生虫界面的表皮(皮肤)中表达。重组 SmCA 在 CO 水合反应中具有高催化活性,与人类 CA 同工型 II 的活性相似,k 为 1.2×10 s,k/K 为 1.3×10 M·s。已经发现,使用 RNA 干扰抑制 SmCA 基因的血吸虫无法在小鼠中建立强大的感染,这表明抑制 SmCA 功能的化学物质应该对寄生虫具有相同的削弱作用。在这项研究中,研究了一系列芳香族/杂环磺酰胺作为可能的 SmCA 抑制剂。一些磺酰胺以中等至弱的效力抑制 SmCA(K 值为 737.2 nM-9.25 μM),而一些杂环化合物以 124-325 nM 的范围内的 K 值抑制该酶。提议 中的 α-CA,SmCA,作为一种新的抗血吸虫病药物靶点。